Terms: = Brain cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Diagnosis
17 results:
1. Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles.
Salgado CM; Alaggio R; Ciolfi A; Zin A; Diomedi Camassei F; Pedace L; Milano GM; Serra A; Di Giannatale A; Mastronuzzi A; Gianatti A; Bisogno G; Ferrari A; Tartaglia M; Reyes-Múgica M; Locatelli F; Miele E
Mod Pathol; 2023 Feb; 36(2):100039. PubMed ID: 36853789
[TBL] [Abstract] [Full Text] [Related]
2. The different structure-function correlation as measured by OCT and octopus perimetry cluster analysis in intracranial tumor and glaucoma patients.
Li X; Qin J; Cao X; Ren Z; Cui T; Bao Y
Front Endocrinol (Lausanne); 2022; 13():938952. PubMed ID: 35966105
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes.
Molina A; Xiao L; Ostrom QT; Rosas LG; Greenberg PL
Leuk Res; 2022 Aug; 119():106907. PubMed ID: 35772318
[TBL] [Abstract] [Full Text] [Related]
4. Use of Whole-Genome Sequencing for Mitochondrial Disease diagnosis.
Davis RL; Kumar KR; Puttick C; Liang C; Ahmad KE; Edema-Hildebrand F; Park JS; Minoche AE; Gayevskiy V; Mallawaarachchi AC; Christodoulou J; Schofield D; Dinger ME; Cowley MJ; Sue CM
Neurology; 2022 Aug; 99(7):e730-e742. PubMed ID: 35641312
[TBL] [Abstract] [Full Text] [Related]
5. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
[TBL] [Abstract] [Full Text] [Related]
6. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract] [Full Text] [Related]
7. Low conductivity on electrical properties tomography demonstrates unique tumor habitats indicating progression in glioblastoma.
Park JE; Kim HS; Kim N; Kim YH; Kim JH; Kim E; Hwang J; Katscher U
Eur Radiol; 2021 Sep; 31(9):6655-6665. PubMed ID: 33880619
[TBL] [Abstract] [Full Text] [Related]
8. Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature.
Grillo P; DI Giuliano F; Massa R; Mercuri NB; Schirinzi T
Neurol Sci; 2021 Mar; 42(3):905-910. PubMed ID: 33443666
[TBL] [Abstract] [Full Text] [Related]
9. The First Inherited Retinal Disease Registry in Iran: Research Protocol and Results of a Pilot Study.
Sabbaghi H; Daftarian N; Suri F; Mirrahimi M; Madani S; Sheikhtaheri A; Khorrami F; Saviz P; Zarei Nejad M; Tivay A; Shahriari HA; Maleki A; Ahmadi SS; Sargazi M; Cremers FPM; Najafi M; Vona B; Haaf T; Bahena-Carbajal P; Moghadasi A; Naraghi H; Yaseri M; Kheiri B; Kalantarion M; Sabbaghi E; Salami M; Pazooki L; Zendedel K; Mojarrab S; Ahmadieh H
Arch Iran Med; 2020 Jul; 23(7):445-454. PubMed ID: 32657595
[TBL] [Abstract] [Full Text] [Related]
10. Clear Cell Sarcoma of the Kidney.
Aldera AP; Pillay K
Arch Pathol Lab Med; 2020 Jan; 144(1):119-123. PubMed ID: 30917048
[TBL] [Abstract] [Full Text] [Related]
11. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
Schmiegelow K; Levinsen MF; Attarbaschi A; Baruchel A; Devidas M; Escherich G; Gibson B; Heydrich C; Horibe K; Ishida Y; Liang DC; Locatelli F; Michel G; Pieters R; Piette C; Pui CH; Raimondi S; Silverman L; Stanulla M; Stark B; Winick N; Valsecchi MG
J Clin Oncol; 2013 Jul; 31(19):2469-76. PubMed ID: 23690411
[TBL] [Abstract] [Full Text] [Related]
12. Treatment-related myelodysplasia in patients with primary brain tumors.
Baehring JM; Marks PW
Neuro Oncol; 2012 May; 14(5):529-40. PubMed ID: 22459128
[TBL] [Abstract] [Full Text] [Related]
13. Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.
Chamberlain MC; Raizer J
J Neurooncol; 2009 Jun; 93(2):229-32. PubMed ID: 19099199
[TBL] [Abstract] [Full Text] [Related]
14. Tumefactive myelinoclastic diffuse sclerosis--case report.
Obara S; Takeshima H; Awa R; Yonezawa H; Oyoshi T; Nagayama T; Hirano H; Niiro M; Kuratsu J
Neurol Med Chir (Tokyo); 2003 Nov; 43(11):563-6. PubMed ID: 14705325
[TBL] [Abstract] [Full Text] [Related]
15. A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case.
Yan J; Whittom R; Delage R; Drouin R
Cancer Genet Cytogenet; 2003 Jan; 140(2):138-44. PubMed ID: 12645652
[TBL] [Abstract] [Full Text] [Related]
16. Myelodysplastic syndrome following therapy for brain tumor--two case reports.
Sugiyama K; Kurisu K; Arita K; Taniguchi E; Okamura T; Itoh Y; Yamasaki F; Kajiwara Y; Ueda H; Sakai A
Neurol Med Chir (Tokyo); 2002 Apr; 42(4):170-4. PubMed ID: 12013670
[TBL] [Abstract] [Full Text] [Related]
17. Myelinoclastic diffuse sclerosis presenting as a mass lesion in a child with Turner's syndrome.
Stachniak JB; Mickle JP; Ellis T; Quisling R; Rojiani AM
Pediatr Neurosurg; 1995; 22(5):266-9. PubMed ID: 7547459
[TBL] [Abstract] [Full Text] [Related]
